Clinical Study

Long-Term Study Evaluating The Long-Term Safety And Tolerability Of Once Daily Centanafadine Capsules In Children And Adolescents With Attention-Deficit/Hyperactivity Disorder

Posted Date: Feb 7, 2022

  • Investigator: Luis Patino Duran
  • Specialties: ADD/ADHD, Adolescent Psychiatry/Psychology
  • Type of Study: Drug

Long-term Safety of Centanafadine in Children and Adolescents With Attention-deficit/Hyperactivity Disorder


Males And Females Aged 4 To 17 Years


Adhd, Attention, Kids

For More Information:

Bhavana Ramachandran
(513) 558-4413

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.